| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.013 | 0.9 |